ValiRx (VAL) Competitors GBX 0.54 +0.01 (+1.90%) As of 03/28/2025 12:22 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock VAL vs. HNR, NOG, EOG, SUN, WRES, EQT, CRC, WEB, NBL, and FTOShould you be buying ValiRx stock or one of its competitors? The main competitors of ValiRx include Highlands Natural Resources (HNR), Nostrum Oil & Gas (NOG), Europa Oil & Gas (EOG), Surgical Innovations Group (SUN), W Resources (WRES), EQTEC (EQT), Circle Property (CRC), Webis (WEB), 18564 (NBL.L) (NBL), and 2059984 (FTO.L) (FTO). These companies are all part of the "petroleum and natural gas" industry. ValiRx vs. Highlands Natural Resources Nostrum Oil & Gas Europa Oil & Gas Surgical Innovations Group W Resources EQTEC Circle Property Webis 18564 (NBL.L) 2059984 (FTO.L) ValiRx (LON:VAL) and Highlands Natural Resources (LON:HNR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, community ranking, dividends and analyst recommendations. Does the media prefer VAL or HNR? In the previous week, ValiRx's average media sentiment score of 0.00 equaled Highlands Natural Resources'average media sentiment score. Company Overall Sentiment ValiRx Neutral Highlands Natural Resources Neutral Is VAL or HNR more profitable? Highlands Natural Resources has a net margin of 0.00% compared to ValiRx's net margin of -20,554.01%. Highlands Natural Resources' return on equity of 0.00% beat ValiRx's return on equity.Company Net Margins Return on Equity Return on Assets ValiRx-20,554.01% -55.84% -35.98% Highlands Natural Resources N/A N/A N/A Does the MarketBeat Community prefer VAL or HNR? ValiRx received 109 more outperform votes than Highlands Natural Resources when rated by MarketBeat users. However, 58.57% of users gave Highlands Natural Resources an outperform vote while only 51.55% of users gave ValiRx an outperform vote. CompanyUnderperformOutperformValiRxOutperform Votes15051.55% Underperform Votes14148.45% Highlands Natural ResourcesOutperform Votes4158.57% Underperform Votes2941.43% Which has preferable earnings and valuation, VAL or HNR? Highlands Natural Resources has higher revenue and earnings than ValiRx. ValiRx is trading at a lower price-to-earnings ratio than Highlands Natural Resources, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioValiRx£27.78K73.11-£5.71M-£1.48-0.36Highlands Natural Resources£1.02M0.00N/A-£4.90N/A SummaryHighlands Natural Resources beats ValiRx on 5 of the 8 factors compared between the two stocks. Remove Ads Get ValiRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VAL vs. The Competition Export to ExcelMetricValiRxBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£2.03M£110.48M£5.63B£2.60BDividend Yield0.63%3.78%4.59%4.82%P/E Ratio-0.363.1423.35141.38Price / Sales73.114,278.81387.84282,480.39Price / Cash62.5012.7538.1727.98Price / Book0.2036.766.894.61Net Income-£5.71M-£91.48M£3.20B£5.79B7 Day Performance-7.12%-2.74%-2.99%1.40%1 Month Performance-16.93%59.40%1.63%7.31%1 Year Performance-84.93%85.34%9.45%112.19% ValiRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VALValiRxN/AGBX 0.54+1.9%N/A-84.9%£2.03M£27,777.32-0.365,450Gap UpHNRHighlands Natural ResourcesN/AN/AN/AN/A£6.95M£1.02M-0.9616Gap DownHigh Trading VolumeNOGNostrum Oil & Gas2.3151 of 5 starsGBX 2.53-10.4%GBX 11+334.8%-50.1%£6.66M£206.12M-0.0930News CoverageGap UpEOGEuropa Oil & GasN/AGBX 0.67+7.2%N/A-33.2%£6.43M£3.57M-0.952,850High Trading VolumeSUNSurgical Innovations GroupN/AGBX 0.55+0.2%N/A+13.0%£5.14M£12.54M-21.1180News CoverageWRESW ResourcesN/AN/AN/AN/A£3.89M£3.47M-0.4366Gap DownEQTEQTECN/AGBX 0.53-4.4%N/A-77.1%£1.36M£3.85M-3.09740Gap DownCRCCircle PropertyN/AN/AN/AN/A£1.02M£7.57M50.001,060Gap DownHigh Trading VolumeWEBWebisN/AN/AN/AN/A£157,000.00£49.70M14.1350Gap DownNBL18564 (NBL.L)N/AN/AN/AN/A£0.00N/A0.002,330FTO2059984 (FTO.L)N/AN/AN/AN/A£0.00N/A0.00147,000 Remove Ads Related Companies and Tools Related Companies Highlands Natural Resources Alternatives Nostrum Oil & Gas Alternatives Europa Oil & Gas Alternatives Surgical Innovations Group Alternatives W Resources Alternatives EQTEC Alternatives Circle Property Alternatives Webis Alternatives 18564 (NBL.L) Alternatives 2059984 (FTO.L) Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:VAL) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ValiRx plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ValiRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VAL Stock Free VAL Stock Alerts